All analyses
5 min read

Last updated:

Epigenetic clocks: real usefulness and limits in practice

Epigenetic clocks translate DNA methylation into a quantified biological age. For a health professional, they remain a promising research tool. This guide sets out what they measure, what they already allow, and what should not be expected of them in consultation.

7 studies citedsee the sources

Benjamin Sant

Co-founder of the School of Longevity

Prevention consultation with a person being supported
Prevention consultation with a person being supported

Epigenetic clocks read DNA methylation at thousands of sites

Epigenetic clocks are mathematical models built from methylated DNA marks. They turn it into a quantified biological age from accessible samples. This estimate differs from chronological age in some individuals. It aims to reflect processes linked to aging rather than elapsed time alone. These tools emerged from large-scale association studies.

These clocks measure methylation signatures distributed across the genome. Each model uses a subset of CpG sites selected statistically. These sites are not all linked to aging genes. Interpretation must remain cautious about their biological meaning. The link between score and causal mechanism is not established for all models. That distinction matters to avoid clinical overinterpretation.

The interest lies in the difference between epigenetic age and chronological age. This gap is sometimes called accelerated age. It has been associated with certain risk factors in observational studies. These associations do not prove a causal effect. Use in practice must remain cautious and contextualized. It must take into account the methodological limits of the model used.

What each biological age measurement allows and does not allow
MeasurementPrincipleDocumented useMain limit
Horvath clock (2013)DNA methylation on a selected set of lociEstimation of calendar age in researchCalibrated on age, little information on health status
Second-generation clocksMethylation residual after removing ageRanking groups within the same age rangeSmall differences and counterintuitive interpretation
DunedinPACE (2022)Decline slope of more than 1,000 clinical measures over 20 yearsMeasurement of the pace of aging and comparison of interventionsInstrumental variability of several points
Commercial biological age kitsDNA methylation on a subset of sites, depending on the kitEducational and motivational useNeither validated nor reproducible from one kit to another
Classic clinical indicatorsDirect measurements: blood pressure, glucose, functionMedical decision and follow-upSensitive to the measurement context

What each biological age measurement allows and does not allow

Groups of methylated sites are measured, then summarized by a statistical model into a single value called epigenetic age.

Biological age reads as a reflection of a trajectory, not as an individual verdict

Several clocks exist with different goals. Some predict chronological age. Others aim to predict mortality or disease risk. These differences explain results that vary between studies. The choice of model must be justified by the question asked.

The estimated biological age reflects statistical correlates, not a single mechanism. Factors such as smoking, obesity or certain treatments can be associated with it. These associations are often moderate and vary between populations. They do not allow a conclusion of direct causality. Interpretation must remain descriptive and nuanced.

Reproducibility depends on laboratory and analysis methods. Technical variations can influence results. Comparing scores obtained with different protocols is difficult. This heterogeneity limits the generalization of interpretation thresholds. The absence of standardized reference values complicates clinical use.

Analysis of sources and levels of scientific evidence
Assessing a level of evidence means comparing what a tool adds to the indicators already available, not comparing numbers.

DunedinPACE estimates the pace of aging rather than an isolated age

The potential usefulness concerns research and certain exploratory contexts. These tools can help study factors linked to aging at population level. They do not replace standard clinical assessment. The classic workup remains the foundation of medical decisions. Their added value must be demonstrated in each context of use.

Studies show associations with events, but with variable strength. Predictive accuracy differs depending on the outcome considered. For a given individual, the margin of uncertainty is often large. That uncertainty limits application to precise individual decisions. An isolated gap should not be overinterpreted. The trend across several measurements is more informative than a single value.

In practice, explaining this to the patient must stay clear and honest. What the epigenetic clock measures, and what it does not, must be stated. The emphasis should be on known modifiable factors rather than on the score alone. This approach avoids false reassurance or unjustified worry.

Health professional analyzing biological data on a screen
Interpreting a result requires knowing the method, the platform and the variability of the measurement.

Consumer anti-aging tests remain outside any prescription framework

The main limits concern the lack of standardization between models. There is no universally validated threshold for clinical interpretation. Studies are mostly observational. These factors complicate extrapolation to all contexts.

The functional meaning of the CpG sites used remains partial. Many are not directly involved in aging processes. The score reflects a statistical signal rather than a precise physiological state. That distinction limits mechanistic inferences.

Accessibility and cost do not guarantee clinical relevance. A test must demonstrate decisive added value before being integrated into practice. At present, the evidence is insufficient for routine use. That limit justifies a cautious approach in any clinical use.

Samples and laboratory tests carried out in the lab
Classic tests have a threshold, a course of action and follow-up: that is what makes them actionable.

DNA methylation varies with the tissue sampled and the platform used

Interpretation must take place within the person's overall context. Chronological age, comorbidities and lifestyle provide more decision elements. An isolated epigenetic gap is not enough to change management. This approach limits the risk of overestimating results.

Communicating results requires particular vigilance. Aging must not be embodied in a single number. Language must stay nuanced, stating the uncertainties. Explaining what the test does not allow is as important as explaining what it does.

Knowledge in this field is evolving fast. Current models will probably be improved in the future. That dynamic justifies regularly reassessing their clinical relevance. The professional favors solid scientific evidence.

Reading and interpreting health data by a professional
Comparing two measurements requires the same technique, the same algorithm and the same quality control threshold.

Structuring the consultation when someone arrives with an epigenetic clock result

In summary, epigenetic clocks are statistical tools useful in research. Their direct clinical usefulness remains limited to date. They must not replace clinical assessment or established markers. Cautious, contextualized interpretation is essential.

The key point is to distinguish association from causality. This principle guides the interpretation of these emerging biomarkers. It avoids hasty conclusions while staying open to advances. Scientific nuance must take precedence over technological enthusiasm.

In the future, methodological improvements could clarify their role. For now, the most honest approach is to acknowledge their limits as much as their interest. Epigenetic clocks bring hypotheses, not certainties. That precision limits the risk of mistaken interpretation.

Support interview with the person being followed
An epigenetic clock result is discussed in three steps: the document, the classic workup, the documented decision.

Sources

  1. 1.Horvath S. DNA methylation age of human tissues and cell types. Genome Biol. 2013.
  2. 2.Belsky DW, et al. DunedinPACE, a DNA methylation biomarker of the pace of aging. eLife. 2022.
  3. 3.Belsky DW, et al. Eleven telomere, epigenetic clock, and biomarker-composite quantifications of biological aging: do they measure the same thing? Am J Epidemiol. 2018.
  4. 4.Bell CG, et al. DNA methylation aging clocks: challenges and recommendations. Genome Biol. 2019.
  5. 5.Biomarkers of Aging Consortium. Challenges and recommendations for the translation of biomarkers of aging. Nat Aging. 2024.
  6. 6.Oblak L, et al. A systematic review of biological, social and environmental factors associated with epigenetic clock acceleration. Ageing Res Rev. 2021.
  7. 7.Fitzgerald KN, et al. Potential reversal of epigenetic age using a diet and lifestyle intervention: a pilot randomized clinical trial. Aging (Albany NY). 2021.

Reading studies is one thing, turning them into a plan is another

The Longevity Practitioner certification teaches the method that turns this kind of data into an accompaniment decision: assess, prioritise, plan over 90 days, re-measure, and know when to hand over.

See the certification

11 modules, €2,200. Enrol

Benjamin Sant

Co-founder of the School of Longevity

Cofounder of the School of Longevity with Tristan Maruyama. A former officer trained at Saint-Cyr from 2019 to 2022 and a coach since 2018, he has supported more than 4,000 people. He leads the School's editorial content with one constant principle: pass on only what can be situated, verified and applied seriously.

This article is published for information and education. It does not replace medical advice. For any personal health question, consult a healthcare professional.